Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00059046 · ClinicalTrials.gov registry record
Brain Imaging of Serotonin Transporters in the Brain
A clinical trial, sponsored by National Institute of Mental Health (NIMH).
- Completed
- Registry status
- 20
- Enrollment target
NCT00059046 is a clinical trial that has completed, run by National Institute of Mental Health (NIMH). The registered enrollment target is 20 participants.
The verdict
NCT00059046 has completed, sponsored by National Institute of Mental Health (NIMH).
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
Serotonin is a chemical involved in the regulation of emotions, anxiety, sleep, stress, and other body functions. The purpose of this study is to use brain imaging technology to study how serotonin works in the brain. The serotonin transporter (SERT) regulates the release of sertonin throughout the body. Until recently, radioactive chemicals called tracers were not suitable for viewing SERT activity. However, a newly developed tracer called \[11C\]DASB can be used with positron emission tomography (PET) imaging to view the parts of the brain that use serotonin. Participants in this study will be screened with medical and psychiatric examinations, an electrocardiogram (EKG), and blood and urine tests. This study comprises two parts. During Part 1, participants will undergo a whole-body PET scan. During Part 2, participants will undergo a magnetic resonance imaging (MRI) scan of the brain. At the next study visit, participants will have one or two PET head scans. If not is not possible to perform both scans on the same day, an additional visit will be scheduled for the second PET scan.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2003-04 |
| Est. Completion | 2005-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00059046
The ClinicalTrials.gov registry entry for NCT00059046 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Mental Health (NIMH), which has 343 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00059046 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00059046 about?
NCT00059046 is a clinical study titled "Brain Imaging of Serotonin Transporters in the Brain". Serotonin is a chemical involved in the regulation of emotions, anxiety, sleep, stress, and other body functions. The purpose of this study is to use brain imaging technology to study how serotonin works in the brain. The serotonin transporter (SERT) regulates the release of sertonin throughout the...
What is the current status of trial NCT00059046?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2003-04. Estimated completion is 2005-01.
Who is sponsoring clinical trial NCT00059046?
This trial is sponsored by National Institute of Mental Health (NIMH), which has 343 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.